Facebook
Twitter
Telegram
Report an ErrorENDRA Life Sciences Financial Statements 2011-2024 | NDRA
Annual Financial Statements ENDRA Life Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.03 M | 11.6 M | 911 K | 36.5 M | 11.2 M | 9.82 M | 9.37 M | - | - | - | - | - | - |
Shares |
10.4 M | 3.17 M | 2.13 M | 19.2 M | 7.5 M | 4.5 M | 2.76 M | - | - | - | - | - | - |
Historical Prices |
0.58 | 3.67 | 0.428 | 2.5 | 1.1 | 1.65 | 3.04 | - | - | - | - | - | - |
Net Income |
-10.1 M | -13.2 M | -11.2 M | -11.7 M | -13.3 M | -9.8 M | -5.38 M | -2.78 M | -2.28 M | -2.18 M | - | - | - |
Revenue |
- | - | - | - | - | 6.17 K | 352 K | 516 K | 1.41 M | 559 K | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | 173 K | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 6.17 K | 179 K | 280 K | 744 K | 300 K | - | - | - |
Operating Income |
-10.5 M | -13.2 M | -11.5 M | -11.5 M | -10.8 M | -9.02 M | -4.63 M | -1.79 M | - | - | - | - | - |
Interest Expense |
460 K | -21.5 K | -41.5 K | 8.84 K | -107 K | -48 K | 42.6 K | 72 K | - | - | - | - | - |
EBITDA |
-10.4 M | -13.1 M | -11.4 M | -11.3 M | -10.7 M | -8.66 M | -4.56 M | -1.73 M | -1.5 M | -1.49 M | - | - | - |
Operating Expenses |
10.5 M | 13.2 M | 11.5 M | - | 10.8 M | 8.74 M | 4.8 M | 2.07 M | 2.31 M | 1.83 M | - | - | - |
General and Administrative Expenses |
4.7 M | 5.17 M | 4.94 M | 5 M | 3.86 M | 3.75 M | 2.75 M | 1.54 M | 1.22 M | 897 K | - | - | - |
All numbers in USD currency
Quarterly Income Statement ENDRA Life Sciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
10.9 M | 10.4 M | 8.41 M | 7.48 M | 3.17 M | 3.17 M | 63.2 M | 63.2 M | 43.1 M | 42.6 M | 41.9 M | 41.7 M | 37.8 M | 34 M | 23.9 M | 14.7 M | 11.5 M | 8.42 M | 7.43 M | 7.42 M | 7.42 M | 7.42 M | 3.93 M | 3.92 M | 3.92 M | 3.92 M | 3.91 M | 2.44 M | 723 K | 723 K | 723 K | 723 K | 723 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.78 M | - | -3.1 M | -2.56 M | -2.94 M | - | -3.44 M | -3.59 M | -2.86 M | - | -2.66 M | -3.2 M | -2.27 M | - | -3.26 M | -2.89 M | -3.32 M | - | -3.41 M | -2.33 M | -2.75 M | - | -2.76 M | -1.85 M | -2.83 M | - | -909 K | -1.43 M | -742 K | - | -978 K | -729 K | -379 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.17 K | - | 287 K | 57.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 118 K | 51.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.17 K | - | 169 K | 6.34 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.78 M | - | -3.13 M | -2.99 M | -2.94 M | - | -3.42 M | -3.57 M | -2.86 M | - | -2.65 M | -3.2 M | -2.58 M | - | -3.26 M | -2.89 M | -3.1 M | - | -2.64 M | -2.33 M | -2.75 M | - | -2.36 M | -1.82 M | -2.84 M | - | -911 K | -1.06 M | -361 K | - | -605 K | -494 K | -373 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-4.84 K | - | 28.2 K | - | - | - | - | - | - | - | -7.51 K | 1.09 K | -2.04 K | - | -2.62 K | 1.26 K | 6.62 K | - | -44.6 K | -9.2 K | -1.52 K | - | -25.5 K | -23.7 K | 12.3 K | - | 2.03 K | 374 K | 28.1 K | - | 373 K | 235 K | -6.02 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-2.77 M | - | -3.1 M | -2.96 M | -2.9 M | - | -3.35 M | -3.55 M | -2.84 M | - | -2.56 M | -3.14 M | -2.54 M | - | -3.21 M | -2.85 M | -3.08 M | - | -2.58 M | -2.29 M | -2.73 M | - | -2.31 M | -1.79 M | -2.82 M | - | -865 K | -1.03 M | -345 K | - | -556 K | -462 K | -357 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.78 M | - | 3.13 M | 2.99 M | 2.94 M | - | 3.42 M | 3.57 M | 2.86 M | - | 2.65 M | 3.2 M | 2.58 M | - | 3.26 M | 2.89 M | 3.1 M | - | 2.64 M | 2.33 M | 2.75 M | - | 2.36 M | 1.82 M | 2.84 M | - | 1.08 M | 1.06 M | 361 K | - | 605 K | 494 K | 373 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.5 M | - | 1.25 M | 1.35 M | 1.37 M | - | 1.17 M | 1.38 M | 1.3 M | - | 1.2 M | 1.2 M | 1.27 M | - | 1.35 M | 1.27 M | 1.47 M | - | 1.07 M | 932 K | 917 K | - | 833 K | 942 K | 1.07 M | - | 732 K | 882 K | 264 K | - | 452 K | 385 K | 274 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency